血管体导向血运重建在重症肢体缺血患者中的系统评价与荟萃分析
该系统评价与荟萃分析纳入19项队列研究共3932例重症肢体缺血伴组织缺损患者,比较直接血运重建(DR)与间接血运重建(IR)的结局。DR显著改善伤口愈合(RR 0.60,95%CI 0.51-0.71)、降低大截肢率(RR 0.56,95%CI 0.47-0.67)并改善无截肢生存率(RR 0.83,95%CI 0.69-1.00),但总体生存无显著差异;在存在侧支循环时DR与IR结局相似,且血管体理论在旁路手术中适用性较低。
要点
- 血管体导向直接血运重建可显著改善重症肢体缺血患者的伤口愈合和大截肢率。
- 存在侧支循环时,间接血运重建与直接血运重建的伤口愈合和大截肢结局相似。
- 旁路手术中血管体理论适用性较低,因旁路常吻合于受累最轻的动脉。
核心结论
- 在重症肢体缺血伴组织缺损患者中,血管体导向直接血运重建较间接血运重建显著改善伤口愈合、降低大截肢率并改善无截肢生存率。
- 在存在侧支循环的情况下,间接血运重建的伤口愈合和大截肢结局与直接血运重建相似。
- 血管体理论在旁路手术中适用性较低,因为旁路通常吻合于受累最轻的动脉以维持通畅。
研究设计与样本
- 系统评价与荟萃分析,遵循Cochrane协作网指定工具及MOOSE标准。
- 检索MEDLINE、Embase和Cochrane中心对照试验注册库,筛选出19项队列研究共3932例患者。
- 其中9项研究在Newcastle-Ottawa量表评分≥7分。
主要发现
- 直接血运重建较间接血运重建显著改善伤口愈合(RR 0.60,95%CI 0.51-0.71)。
- 直接血运重建较间接血运重建显著降低大截肢率(RR 0.56,95%CI 0.47-0.67)。
- 直接血运重建较间接血运重建改善无截肢生存率(RR 0.83,95%CI 0.69-1.00)。
- 总体生存率无显著差异。
- 在旁路手术研究的敏感性分析中,大截肢的显著性丢失;在按侧支循环分层的研
临床怎么用
- 对于重症肢体缺血伴组织缺损且接受腔内治疗的患者,可优先考虑血管体导向直接血运重建以改善伤口愈合和降低大截肢风险。
- 对于存在侧支循环的患者,间接血运重建可作为可接受的策略,结局与直接血运重建相似。
- 在旁路手术中应谨慎应用血管体理论,因旁路常吻合于受累最轻的动脉以维持通畅。
局限性
- 纳入研究均为队列研究,证据等级受限。
- 仅9项研究在Newcastle-Ottawa量表评分≥7分。
- 旁路手术研究的敏感性分析中大截肢的显著性丢失。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Direct revascularization (DR), according to the angiosome concept, provides direct blood flow to the site of tissue loss in patients with critical limb ischemia (CLI). DR may lead to improved outcomes; however, evidence for this is controversial. This systematic review and meta-analysis investigated the outcomes of surgical and endovascular DR compared with indirect revascularization (IR) in patients with CLI. METHODS: A systematic review was undertaken using the Cochrane Collaboration specified tool, and a meta-analysis was done according to the MOOSE (Meta-analysis of Observational Studies in Epidemiology) criteria. The electronic databases of MEDLINE, Embase, and the Cochrane Central Register of Controlled Trials were systematically searched for studies of DR compared with IR in patients with CLI with tissue loss. All articles were critically assessed for relevance, validity, and availability of data regarding patient and lesion characteristics and outcomes. When possible, data were systematically pooled, and a meta-analysis was performed for wound healing, major amputation, amputation-free survival, and overall survival. RESULTS: Of 306 screened abstracts, 19 cohort studies with 3932 patients were included. Nine scored 7 or higher on the Newcastle-Ottawa score. DR significantly improved wound healing (risk ratio [RR], 0.60; 95% confidence interval [CI], 0.51-0.71), major amputation (RR, 0.56; 95% CI, 0.47-0.67), and amputation-free survival rates (RR, 0.83; 95% CI, 0.69-1.00) compared with IR. This significance was lost in major amputation on sensitivity analysis for bypass studies. No significant difference was found in overall survival. In studies stratifying for collaterals, no differences between DR and IR were found in wound healing or major amputations in the presence of collaterals. CONCLUSIONS: DR significantly improves wound healing and major amputation rates after endovascular treatment in patients with CLI, supporting the angiosome theory. In the presence of collaterals, outcomes after IR are similar to outcomes after DR. Alternatively, patients without collaterals may benefit even more from DR as a primary treatment strategy. The angiosome theory is less applicable in bypass surgery, because bypasses are generally anastomosed to the least affected artery, with runoff passing the ankle to maintain bypass patency.
引用
- Jongsma H, Bekken JA, Akkersdijk GP, et al. Angiosome-directed revascularization in patients with critical limb ischemia. J Vasc Surg. 2017. PMID: 28342514. doi:10.1016/j.jvs.2016.10.100
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。